메뉴 건너뛰기




Volumn 118, Issue 3, 2002, Pages 728-740

Immunotherapy for post-transplant lymphoproliferative disease

Author keywords

Cytotoxic T cells; Epstein Barr virus; Immunotherapy; Lymphoproliferative disease; Transplantation

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; B LYMPHOCYTE ANTIBODY; CD2 ANTIGEN; CD20 ANTIGEN; CD24 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GANCICLOVIR; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; MONOCLONAL ANTIBODY CD21; MONOCLONAL ANTIBODY CD24; MONOCLONAL ANTIBODY CD3; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

EID: 0036041116     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03594.x     Document Type: Review
Times cited : (62)

References (97)
  • 22
    • 0032521217 scopus 로고    scopus 로고
    • Malignancies after hemopoietic stem cell transplantation: Many questions, some answers
    • (1998) Blood , vol.91 , pp. 1833-1844
    • Deeg, H.J.1    Socie, G.2
  • 39
    • 0032522959 scopus 로고    scopus 로고
    • Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants
    • (1998) Blood , vol.91 , pp. 3079-3083
    • Hale, G.1    Waldmann, H.2
  • 76
    • 0028356401 scopus 로고
    • Increased levels of circulating Epstein-Barr virus (EBV) -infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
    • (1994) Blood , vol.84 , pp. 972-984
    • Riddler, S.A.1    Breinig, M.C.2    McKnight, J.L.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.